Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase EARLY_PHASE1 5Phase 1 5Phase 3 3Phase 1/2 2Phase NA 1

Status

Completed 5

Sponsor Class

INDUSTRY 10OTHER 5NIH 2NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 2Tumor-Agnostic 1CNS 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2Neuroblastoma 1Neoplasms 1Advanced Cancer 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Ketoconazole × Clear all
NCT00295919 2026-04-14

N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed
80 enrolled
CNS

Neuroblastoma

NCT00096317 2018-10-31

Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors

Montefiore Medical Center

Phase 1 Completed
29 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00708591 2014-01-17

Study of Rapamycin Plus Ketoconazole in Advanced Cancers

University of Chicago

Phase 1 Completed
57 enrolled

Advanced Cancer

NCT00238225 2013-01-31

Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors

Roswell Park Cancer Institute

Phase 1 Completed
15 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01548170 2012-03-08

To Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of Sunitinib

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Phase 1 Completed
12 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡